Written by students who passed Immediately available after payment Read online or as PDF Wrong document? Swap it for free 4.6 TrustPilot
logo-home
Document preview thumbnail
Preview 4 out of 37 pages
Exam (elaborations)

NSG 552 Psychopharmacology Exams 1 2 3 Wilkes University Official Practice Exam Actual Exam 2026/2027 with Detailed Rationales | Complete Exam-Style Questions | Pass Guaranteed – A+ Graded

Document preview thumbnail
Preview 4 out of 37 pages

NSG 552 Psychopharmacology Exams 1 2 3 Wilkes University Official Practice Exam Actual Exam 2026/2027 – Real-Style Exam Questions | 100% Correct Answers | Neurotransmitter Systems | Antidepressants | Antipsychotics | Mood Stabilizers | Anxiolytics | Stimulants | Drug Interactions | Adverse Effects | Clinical Applications | Detailed Rationales | Graded A+ Verified – Pass Guaranteed – Instant Download

Content preview

​ SG 552 Psychopharmacology Exams 1 2 3​
N
​Wilkes University Official Practice Exam Actual​
​Exam 2026/2027 with Detailed Rationales |​
​Complete Exam-Style Questions | Pass​
​Guaranteed – A+ Graded​
​ ═════════════════════════════════════​

​SECTION 1: NEUROBIOLOGY & MECHANISMS OF ACTION Q1 – Q10​
​══════════════════════════════════════​


​Question 1 of 50​


​A 24-year-old male recently diagnosed with schizophrenia is started on aripiprazole. He​

​asks the advanced practice psychiatric-mental health nurse practitioner how the​

​medication works. The PMHNP explains that aripiprazole acts primarily as a dopamine​

​D2 partial agonist. What is the clinical significance of this mechanism compared to full​

​antagonists like haloperidol?​


​ . It completely blocks dopamine release in the mesolimbic pathway, causing​
A
​immediate sedation.​
​B. It increases dopamine synthesis in the frontal cortex to treat negative symptoms​
​exclusively.​
​C. It stabilizes dopamine activity by acting as an antagonist in high-dopamine states​
​and an agonist in low-dopamine states. ✓ CORRECT​
​D. It prevents serotonin reuptake in the synaptic cleft, enhancing the mood-stabilizing​

​effects.​


​Correct Answer: C​

,​Rationale: Aripiprazole is a dopamine D2 partial agonist that stabilizes dopamine​

​transmission, reducing positive symptoms without causing complete blockade in the​

​nigrostriatal pathway. Tempting wrong answers suggesting full D2 antagonism​

​misrepresent the drug's mechanism, as full antagonists like haloperidol carry a much​

​higher risk of extrapyramidal symptoms. Always remember partial agonists act as​

​functional antagonists in high-dopamine states.​


​Question 2 of 50​


​A 42-year-old female with major depressive disorder is prescribed fluoxetine. She is​

​currently taking metoprolol for hypertension. During a follow-up visit, she reports​

​dizziness and profound bradycardia. What is the most likely pharmacokinetic​

​mechanism causing this interaction?​


​ . Fluoxetine induces the CYP2D6 enzyme, rapidly decreasing metoprolol plasma​
A
​concentrations.​
​B. Fluoxetine inhibits the CYP2D6 enzyme, leading to toxic accumulation of metoprolol.​
​C. Fluoxetine blocks the P-glycoprotein transporter, altering renal excretion of​
​metoprolol.​
​D. Fluoxetine competes for plasma protein binding, displacing metoprolol into the​

​tissues.​


​ orrect Answer: B​
C
​Rationale: Fluoxetine is a potent inhibitor of the CYP2D6 enzyme, which reduces the​

​metabolism of beta-blockers like metoprolol and leads to toxic bradycardia. Answer​

​choices suggesting enzyme induction are incorrect because fluoxetine does not induce​

​CYP2D6; it inhibits it. When prescribing fluoxetine with CYP2D6 substrates, always​

​consider dose reductions to prevent adverse events.​

,​Question 3 of 50​


​A 55-year-old male presents to the emergency department with severe alcohol​

​withdrawal and agitation requiring intramuscular sedation. The PMHNP considers​

​lorazepam over diazepam. What property of lorazepam makes it the preferred agent in​

​this acute, parenteral scenario?​


​ . Lorazepam has less reliance on hepatic oxidation and undergoes glucuronidation,​
A
​making it safer in hepatic impairment. ✓ CORRECT​
​B. Lorazepam is highly lipid-soluble, allowing it to cross the blood-brain barrier faster​
​than diazepam.​
​C. Lorazepam has a longer half-life than diazepam, providing more prolonged seizure​
​prophylaxis.​
​D. Lorazepam does not bind to GABA receptors, reducing the risk of respiratory​

​depression.​


​ orrect Answer: A​
C
​Rationale: Lorazepam undergoes phase II glucuronidation without relying on hepatic​

​oxidation, making its metabolism less affected by liver disease or aging compared to​

​diazepam. Answer choices suggesting higher lipid solubility are incorrect because​

​diazepam is actually more lipid-soluble, leading to a faster onset but also rapid​

​redistribution. For acute alcohol withdrawal in patients with potential liver impairment,​

​lorazepam is the safest choice.​


​Question 4 of 50​


​A 38-year-old patient with a history of severe substance use disorder is prescribed a​

​novel medication that acts as an inverse agonist at the benzodiazepine receptor site.​

​What is the expected clinical effect of this drug?​

, ​ . Profound sedation and anxiolysis similar to traditional benzodiazepines.​
A
​B. Severe anxiety, agitation, and potential pro-convulsant effects. ✓ CORRECT​
​C. Complete blockade of GABA receptors without altering baseline activity.​
​D. Mild sedation combined with significant muscle relaxation.​


​ orrect Answer: B​
C
​Rationale: An inverse agonist binds to the same receptor as an agonist but induces a​

​pharmacological response opposite to that of the agonist, reducing GABAergic activity​

​and causing anxiety or seizures. Answer choices suggesting sedation are incorrect​

​because they describe agonist or partial agonist effects rather than inverse agonism.​

​Flumazenil acts as a competitive antagonist, whereas inverse agonists actively shift the​

​receptor conformation.​


​Question 5 of 50​


​A 29-year-old female has been taking sertraline 50 mg for six weeks with minimal​

​improvement in her depressive symptoms. The PMHNP explains that the delayed onset​

​of antidepressant effect is due to downstream signal transduction changes. What​

​neurobiological adaptation is primarily responsible for the therapeutic lag?​


​ . Immediate downregulation of presynaptic serotonin autoreceptors.​
A
​B. Rapid desensitization of postsynaptic 5-HT1A receptors within 48 hours.​
​C. Upregulation of serotonin transporters leading to increased synaptic clearance.​
​D. Downregulation of postsynaptic serotonin receptors and increased neuroplasticity​

​over time. ✓ CORRECT​


​ orrect Answer: D​
C
​Rationale: The therapeutic lag of SSRIs is primarily due to the time required for​

​postsynaptic receptor downregulation and subsequent increases in brain-derived​

Document information

Uploaded on
August 1, 2026
Number of pages
37
Written in
2026/2027
Type
Exam (elaborations)
Contains
Questions & answers
$15.49

Wrong document? Swap it for free Within 14 days of purchase and before downloading, you can choose a different document. You can simply spend the amount again.
Written by students who passed
Immediately available after payment
Read online or as PDF

Sold
0
Followers
0
Items
110
Last sold
-


Why students choose Stuvia

Created by fellow students, verified by reviews

Quality you can trust: written by students who passed their exams and reviewed by others who've used these revision notes.

Didn't get what you expected? Choose another document

No problem! You can straightaway pick a different document that better suits what you're after.

Pay as you like, start learning straight away

No subscription, no commitments. Pay the way you're used to via credit card and download your PDF document instantly.

Student with book image

“Bought, downloaded, and smashed it. It really can be that simple.”

Alisha Student

Working on your references?

Create accurate citations in APA, MLA and Harvard with our free citation generator.

Working on your references?

Frequently asked questions